Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Trazzi

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|June 2, 2021
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of <i>CDKL5</i> Deficiency DisorderManuela Loi, Laura Gennaccaro, Claudia Fuchs, et al.
International Journal of Molecular Sciences|March 28, 2026
Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult <i>Cdkl5</i> KO MiceManuela Loi, Nicola Mottolese, Giorgio Medici, et al.
Neural Plasticity|July 7, 2018
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 DisorderClaudia Fuchs, Laura Gennaccaro, Stefania Trazzi, et al.
Frontiers in Cellular Neuroscience|May 23, 2019
Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB AgonistElisa Ren, Vincenzo Roncacé, Stefania Trazzi, et al.
Frontiers in Bioengineering and Biotechnology|February 6, 2026
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoidsGiorgio Medici, Angelica M Bove, Stefania Trazzi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2024
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndromeCeleste Ferraguto, Marion Piquemal-Lagoueillat, Valerie Lemaire, et al.
International Journal of Molecular Sciences|March 13, 2025
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency DisorderManuela Loi, Francesca Valenti, Giorgio Medici, et al.
Human Molecular Genetics|July 29, 2016
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorderStefania Trazzi, Claudia Fuchs, Rocchina Viggiano, et al.
Neurobiology of Disease|February 23, 2021
A GABA<sub>B</sub> receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorderLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Human Molecular Genetics|February 24, 2018
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorderStefania Trazzi, Marianna De Franceschi, Claudia Fuchs, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|June 2, 2021
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of <i>CDKL5</i> Deficiency DisorderManuela Loi, Laura Gennaccaro, Claudia Fuchs, et al.
International Journal of Molecular Sciences|March 28, 2026
Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult <i>Cdkl5</i> KO MiceManuela Loi, Nicola Mottolese, Giorgio Medici, et al.
Neural Plasticity|July 7, 2018
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 DisorderClaudia Fuchs, Laura Gennaccaro, Stefania Trazzi, et al.
Frontiers in Cellular Neuroscience|May 23, 2019
Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB AgonistElisa Ren, Vincenzo Roncacé, Stefania Trazzi, et al.
Frontiers in Bioengineering and Biotechnology|February 6, 2026
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoidsGiorgio Medici, Angelica M Bove, Stefania Trazzi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2024
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndromeCeleste Ferraguto, Marion Piquemal-Lagoueillat, Valerie Lemaire, et al.
International Journal of Molecular Sciences|March 13, 2025
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency DisorderManuela Loi, Francesca Valenti, Giorgio Medici, et al.
Human Molecular Genetics|July 29, 2016
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorderStefania Trazzi, Claudia Fuchs, Rocchina Viggiano, et al.
Neurobiology of Disease|February 23, 2021
A GABA<sub>B</sub> receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorderLaura Gennaccaro, Claudia Fuchs, Manuela Loi, et al.
Human Molecular Genetics|February 24, 2018
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorderStefania Trazzi, Marianna De Franceschi, Claudia Fuchs, et al.
Pageof 5